Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Camposol Holding PLC reports Preliminary First Quarter 2025 Results.
-
BIO-key and Runlevel Secure First Major IAM Deployment with a National Bank in Mozambique; Extends Growing List of Banking Customers
-
Novartis announces commencement of tender offer to acquire Regulus Therapeutics
-
Disclosure of Shareholding – Gjelsten Holding AS
-
ZLNA – New registered share capital
-
With Support from Solana's Co-Founder Toly, OctonetAI Launches OctoMCP and Prepares for AI-Powered Smart Contract Audits
-
With Support from Solana's Co-Founder Toly, OctonetAI Launches OctoMCP and Prepares for AI-Powered Smart Contract Audits
-
SciSparc Announces Publication of Japanese Patent Application
-
Purpose Investments Inc. Announces Final May 2025 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund
-
Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases
-
Evaxion announces business update and first quarter 2025 financial results
-
Urgently Promotes Michael Port to Chief Financial Officer
-
BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor
-
American Tungsten Corp. Commences Mine Site Preparation and Exploration Work
-
Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report
-
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
-
Swvl Secures 3-Year Contract Worth Up to $4 Million with a Large Enterprise in Essential Services
-
ARMLOGI HOLDING CORP. ADDED TO MEMBERSHIP OF RUSSELL MICROCAP® INDEX
-
NETCLASS TECHNOLOGY INC. and East China Normal University Sign Cooperation Agreement to Pioneer a New Era of Smart Education
-
Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies
-
Regula Rolls Out Personal Data Masking Across All Solutions for Easier Privacy Compliance
-
FinWise Bancorp Added to Membership of US Small-Cap Russell 2000® Index
-
Adagene to Present at Jefferies Global Healthcare Conference 2025
-
Nexxen Announced as a Preliminary Addition to the Russell 3000 Index
-
ZA Miner Launches New 3-Day Short-Term Cloud Mining Contracts for May 2025 — Built for XRP Holders Seeking Fast Passive Returns
-
Canstar Ramps Up Critical Minerals Exploration With Initial Payment from $11.5M Strategic Exploration JV
-
Form 8.5 (EPT/RI) - Inspired Plc
-
Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities
-
Gilat Receives Over $25 Million in Orders for its Multi-Orbit Satellite Solutions
-
Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST—Modifier Gene Therapy for the Treatment of Stargardt Disease
-
Key information relating to the cash dividend to be paid by Golar LNG Limited (Ticker: GLNG)
-
Invivyd Announces Publication of Landmark CANOPY Phase 3 PEMGARDA® (pemivibart) Clinical Trial; Results Underscore Strong Efficacy of Monoclonal Antibodies in Preventing COVID-19 in a Modern U.S. Pop
-
BioCryst to Present at Upcoming Investor Conferences
-
Emerita Achieves 81.5% Gold Recovery for 27% Improvement Over Previous Metallurgical Testing for IBW Project
-
Q2 Metals Expands Major Lithium Zone at the Cisco Lithium Project: Hole 27 Drilled 179.6 Metres at 1.66% Li₂O, 58.0 Metres at 1.75% Li₂O, and 91.8 Metres at 1.81% Li₂O
-
EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYU™ for Treatment of Wet Age-Related Macular Degeneration
-
Fury Announces C$4.3M Strategic Investment
-
GlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases
-
Xtract One Teams Up with MLB’s Colorado Rockies to Deploy SmartGateway at Coors Field, Bringing Frictionless Screening to Fans this Season
-
Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
-
BioXcel Therapeutics Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirement
-
Serco Completes Acquisition of Northrop Grumman’s Mission Training & Satellite Ground Network Communications Software Business
-
Tango Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
-
Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting
-
U.S. Department of the Interior Greenlights Anfield’s Velvet-Wood Uranium-Vanadium Mine
-
REPEAT – Koryx Copper Announces Further Highly Encouraging Drill Results at the Haib Copper Project, Southern Namibia
-
Indonesia Energy Provides Update on its Strategic Vision and Dedication to the Future of Energy Development in Indonesia
-
RYVYL Receives Extension to Comply with Nasdaq Listing Rule 5550(b)
-
OTC Markets Group Welcomes Greenheart Gold Inc. to OTCQX
-
NewGen Announces Strategic Expansion with Services Tailored for Indian Medical Tourists

